A driver of the bone cancer osteosarcoma was discovered by Professor Adrienne Flanagan (UCL Cancer Institute) and researchers from EMBL EBI and the Royal National Orthopaedic Hospital, which could help to predict cancer severity and how patients will respond to treatment.
Read: El Pais (Spanish), More: La Razon (Spanish), UCL News
Close
